Doug Treco
Advisor at Lightstone Ventures
About
Advisor who co-founded Ra Pharmaceuticals and served as its CEO until its acquisition by UCB in 2020. He also co-founded Transkaryotic Therapies and was previously an Entrepreneur-in-Residence at Morgenthaler Ventures.
Colleagues at Lightstone Ventures
Brendan Kelly
Principal at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures